ADHD Medication, Appetite and Weight

Why appetite drops

Stimulant medicines act on dopamine and noradrenaline, and those systems are involved in appetite as well as attention. Suppressed appetite is therefore an expected pharmacological effect rather than a sign that something has gone wrong.

In practice it usually shows up as simply not being hungry at the times you would normally eat. Breakfast may be fine, because it is taken before or with the dose, and lunch is the meal most often missed. Appetite frequently returns in the evening as the medicine wears off, which is why some people eat very little all day and then a great deal at night.

The effect is usually strongest in the first days to weeks and often settles at least partly. Our guide to titration explains why the early weeks are the period where this is watched most closely.

Which medicines affect appetite

Scroll the table sideways to see every column.

Duration matters as much as the drug. A twelve or fourteen hour product covers both lunch and, for some people, the early evening, so there is a smaller window in which appetite returns. A shorter-acting option leaves more of the day clear.

That is one of the reasons a change of formulation sometimes solves an appetite problem without changing the underlying medicine.

Appetite and growth in children

This is monitored formally rather than left to judgement. Height and weight are checked at every review throughout treatment, not only during titration, because stimulants can slow growth in some children.

Parents often find the evening rebound useful rather than a problem. If a child eats little at lunch but is genuinely hungry at seven, moving the substantial meal to then is usually more effective than trying to force lunch.

Appetite and weight in adults

Adults are not monitored as formally as children, which means the responsibility for noticing a trend falls on you. Weighing yourself occasionally in the first few months is a reasonable habit, not because a number matters in itself but because a steady drift is easier to spot on a chart than in a mirror.

The pattern most adults describe is forgetting to eat rather than actively avoiding food. Hunger is the usual prompt for a meal, and when that prompt is muted a working day can pass without anything being eaten. Setting a reminder is an unglamorous fix that works better than intending to remember.

There is also an interaction worth naming. For some adults, appetite suppression is initially welcome, particularly where weight has been a long-standing concern. That is understandable, but it makes it easier to miss the point at which loss stops being incidental. If you find yourself pleased about it, that is a good reason to mention it at review rather than a reason not to.

Anyone with a history of disordered eating should raise it before starting treatment. It does not preclude medication, but it changes what is monitored and how often, and a prescriber can only account for it if they know.

What actually helps

Most appetite problems are managed by changing when and what is eaten rather than by changing medicine. These are the adjustments prescribers suggest most often.

• Eat breakfast before or with the dose, while appetite is still normal
• Move the largest meal to the evening, when appetite typically returns
• Make what is eaten count: calorie-dense rather than large
• Set a reminder to eat at lunch rather than waiting to feel hungry
• Keep easy food available for the evening window
• Do not skip meals to lose weight deliberately while on treatment

If those do not work, the next step is a conversation about dose and timing rather than about stopping. Lowering a dose, moving it earlier, or switching to a shorter-acting formulation all change the size of the window in which appetite is suppressed.

The binge eating disorder question

This comes up because of an American licence. In the United States, lisdexamfetamine, the active ingredient in Elvanse, is approved for the treatment of moderate to severe binge eating disorder in adults, sold there as Vyvanse. It is the only medicine with that approval.

That licence does not exist here. In the UK, lisdexamfetamine is licensed for ADHD only, so prescribing it for binge eating disorder would be off-label and is not routine practice. The American approval is also explicitly not a weight loss indication: it was granted for the frequency of binge episodes, and the US labelling states the medicine is not indicated for weight loss and that the safety of amfetamines for obesity has not been established.

It is still worth knowing, for two reasons. If you have read about it and wondered whether it applies to you, the answer here is a specialist conversation rather than a prescription. And if you have a history of binge eating alongside ADHD, it is a relevant thing to raise at assessment, because it changes what a prescriber watches during treatment.

When to seek advice

Speak to your prescriber if any of the following apply.

• Weight is falling steadily rather than settling
• A child is drifting off their growth curve across successive reviews
• You are consistently unable to eat a full day's food
• Appetite has not recovered at all after the first several weeks
• You feel faint, unusually cold, or persistently exhausted
• Concerns about eating or body image have appeared or worsened

None of these mean treatment has to stop. They mean the current arrangement needs adjusting, which is what reviews are for. Suspected side effects can also be reported through the MHRA Yellow Card scheme.

• Side effects in full What to watch for, and when to seek help
• How titration works How dose and timing are adjusted
• Anxiety Whether medication helps or makes it worse

Common questions